Dear Medical Care Group Business Administrator,
On July 26, 2022, we mailed a letter to one or more of your primary care physicians who have BCN AdvantageSM patients who are eligible for our Blue Cross Personalized MedicineSM pilot program that uses pharmacogenomic (PGx) testing. The full program will launch in January 2023. Attached is a generic copy of the letter and the fact sheet that went to physicians, along with a copy of the letter mailed to members selected for the pilot program.
The physician letter inadvertently stated that there was an upcoming May webinar for providers. Although the date has passed, the webinar link still hosts recorded educational videos.
You may have also received up to three previous emails about this pilot program if you had physicians involved in these earlier mailings:
- Email of March 22, 2022: Letter to physicians with BCN Advantage patients eligible for the first round of this pilot program.
- Email of March 29, 2022: Letter to physicians with Blue Care Network commercial patients eligible for a similar program with a different vendor.
- Email of April 13, 2022: Letter to physicians with BCN Advantage patients eligible for the second round of this pilot program.
If you would like a list of your affected physicians and their members for any of these mailings, please reach out to your provider consultant.